The epidemiology of skin cancer

Photodermatology

Volumn , Issue , 2007, Pages 119-137

  Naldi, Luigi ^a   Diepgen, Thomas ^b  

^a OSPEDALI RIUNITI   (Italy)

^b Occupational and Environmental Dermatology ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052264080     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (126)

1. Weinstock MA. Controversies in the public health approach to keratinocyte carcinomas. Br J Dermatol 2006; 154(suppl):3-4.
2. Last A, Robert A, Spasoff RA, Harris SS. A Dictionary of Epidemiology. 4th ed. Oxford University Press, New York, 2000.
3. Demers AA, Nugent Z, Mihalcioiu C, Wiseman MC, Kliewer EV. Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population. J Am Acad Dermatol 2005; 53:320-328.
4. Rigel DS, Friedman RJ, Kopf AW. Lifetime risk for development of skin cancer in the U.S. population: current estimate is now 1 in 5. J Am Acad Dermatol 1996; 35:1012-1013.
5. Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 2006; 184:6-10.
6. Merrill RM, Feuer EJ. Risk-adjusted cancer-incidence rates (United States). Cancer Cause Control 1996; 7:544-552.
7. de Vries E, van de Poll-Franse LV, Louwman WJ, de Gruijl FR, Coebergh JW. Predictions of skin cancer incidence in the Netherlands up to 2015. Br J Dermatol 2005; 152:481-488.
8. Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer Incidence in Five Continents. Volumes I to VIII. IARC CancerBase No. 7, Lyon, 2005.
9. Burton RC, Armstrong BK. Recent incidence trends imply a nonmetastasizing form of invasive melanoma. Melanoma Res 1994; 4:107-113.
10. Levi F, Te VC, Randimbison L, La Vecchia C. Trends in incidence of various morphologies of malignant melanoma in Vaud and Neuchatel, Switzerland. Eur J Cancer 2004; 40:1630-1633.
11. Osterlind A, Engholm G, Jensen OM. Trends in cutaneous malignant melanoma in Denmark 1943-1982 by anatomic site. APMIS 1988; 96:953-963.
12. Thorn M, Bergstrom R, Adami HO, Ringborg U. Trends in the incidence of malignant melanoma in Sweden, by anatomic site, 1960-1984. Am J Epidemiol 1990; 132:1066-1077.
13. Dennis LK, White E, Lee JA. Recent cohort trends in malignant melanoma by anatomic site in the United States. Cancer Cause Control 1993; 4:93-100.
14. Chen YT, Zheng T, Holford TR, Berwick M, Dubrow R. Malignant melanoma incidence in Connecticut (United States): time trends and age-period-cohort modeling by anatomic site. Cancer Cause Control 1994; 5:341-350.
15. Bulliard JL, Cox B. Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969-1993. Int J Epidemiol 2000; 29:416-423.
16. Cress RD, Holly EA. Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians, and blacks: an analysis of California cancer registry data, 1988-1993. Cancer Cause Control 1997; 8:246-252.
17. Stevens NG, Liff JM, Weiss NS. Plantar melanoma: is the incidence of melanoma of the sole of the foot really higher in blacks than whites? Int J Cancer 1990; 45:691-693.
18. Levi F, Randimbison L, Te VC, La Vecchia C. High constant incidence rates of second cutaneous melanomas. Melanoma Res 2005; 15:73-75.
19. La Vecchia C, Lucchini F, Negri E, Boyle P, Levi F. Trends in cancer mortality in the Americas. Eur J Cancer 1993; 29:431-470.
20. Jemal A, Devesa SS, Fears TR, Hartge P. Cancer surveillance series: changing patterns of cutaneous malignant melanoma mortality rates among whites in the United States. J Natl Cancer Inst 2000; 92:811-818.
21. Severi G, Giles GG, Robertson C, Boyle P, Autier P. Mortality from cutaneous melanoma: evidence for contrasting trends between populations. Br J Cancer 2000; 82:1887-1891.
22. Scotto J, Pitcher H, Lee JAH. Indication of future decreasing trends in skin melanoma mortality among whites in the United States. Int J Cancer 1991; 49:490-497.
23. Giles GG, Armstrong BK, Burton RC, Staples MP, Thursfield VJ. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994. BMJ 1996; 312:1121-1125.
24. Bosetti C, La Vecchia C, Naldi L, Lucchini F, Negri E, Levi F. Mortality from cutaneous malignant melanoma in Europe. Has the epidemic levelled off? Melanoma Res 2004; 14:301-309.
25. La Vecchia C, Negri E, Levi F, Decarli A, Boyle P. Cancer mortality in Europe: effects of age, cohort of birth and period of death. Eur J Cancer 1998; 34:118-141.
26. Streetly A, Markowe H. Changing trends in the epidemiology of malignant melanoma: gender differences and their implications for public health. Int J Epidemiol 1995; 24:897-907.
27. MacKie R, Aitchison TC, Hunter JAA, et al., for The Scottish Melanoma Group. Cutaneous malignant melanoma, Scotland, 1979-1989. Lancet 1992; 339:971-975.
28. de Vries E, Bray FI, Coebergh JW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer 2003; 107:119-126.
29. MacKie RM, Hole D, Hunter JA, et al. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality. The Scottish Melanoma Group, 1979-1994. BMJ 1997; 315:1117-1121.
30. Melia J, Pendry L, Eiser JR, Harland C, Moss S. Evaluation of primary prevention initiatives for skin cancer: a review from a UK perspective. Br J Dermatol 2000; 143:701-708.
31. Scotto J, Fears TR, Fraumeni JF. Incidence of non-melanoma skin cancer in the United States. NIH Pub. no. 83-2433. Bethesda, MD: U.S. Dept. of Health and Human Services, National Institutes of Health, 1983.
32. Christenson LJ, Borrowman TA, Vachon CM, et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA 2005; 294:681-90.
33. Green A, Battistutta D. Incidence and determinants of skin cancer in a high-risk Australian population. Int J Cancer 1990; 46:356-361.
34. Marks R, Jolley D, Dorevitch AP, Selwood TS. The incidence of non-melanocytic skin cancers in an Australian population: results of a five-year prospective study. Med J Aust 1989; 150:475-478.
35. Harris RB, Griffith K, Moon TE. Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985-1996. J Am Acad Dermatol 2001; 45:528-536.
36. Koh D, Wang H, Lee J, Chia KS, Lee HP, Goh CL. Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of the Singapore Cancer Registry data 1968-1997. Br J Dermatol 2003; 148:1161-1166.
37. Gray DT, Suman VJ, Su WP, Clay RP, Harmsen WS, Roenigk RK. Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. Arch Dermatol 1997; 133:735-740.
38. Karagas MR, Greenberg ER, Spencer SK, Stukel TA, Mott LA. Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. Int J Cancer 1999; 81:555-559.
39. Athas WF, Hunt WC, Key CR. Changes in nonmelanoma skin cancer incidence between 1977-1978 and 1998-1999 in Northcentral New Mexico. Cancer Epidemiol Biomarkers Prev 2003; 12:1105-1108.
40. Chuang TY. Skin cancer II. Nonmelanoma skin cancer. In: Williams HC, Strachan DP, eds. The Challenge of Dermatoepidemiology. Boca Raton: CRC Press, 1997:209-222.
41. Gallagher RP, Ma B, McLean DI, et al. Trends in basal cell carcinoma, squamous cell carcinoma, and melanoma of the skin from 1973 through 1987. J Am Acad Dermatol 1990; 23:413-421.
42. Buettner PG, Raasch BA. Incidence rates of skin cancer in Townsville, Australia. Int J Cancer 1998; 78:587-593.
43. Magnus K. The Nordic profile of skin cancer incidence. A comparative epidemiological study of the three main types of skin cancer. Int J Cancer 1991; 47:12-19.
44. Roberts DL. Incidence of non-melanoma skin cancer in West Glamorgan, South Wales. Br J Dermatol 1990; 122:399-403.
45. Holme SA, Malinovszky K, Roberts DL. Changing trends in non-melanoma skin cancer in South Wales, 1988-98. Br J Dermatol 2000; 143:1224-1229.
46. Katalinic A, Kunze U, Schafer T. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol 2003; 149:1200-1206.
47. Stang A, Stegmaier C, Jockel KH. Nonmelanoma skin cancer in the Federal State of Saarland, Germany, 1995-1999. Br J Cancer 2003; 89:1205-1208.
48. Boi S, Cristofolini M, Micciolo R, Polla E, Dalla Palma P. Epidemiology of skin tumors: data from the cutaneous cancer registry in Trentino, Italy. Ann Epidemiol 2003; 13:436-442.
49. Levi F, La Vecchia C, Te VC, Mezzanotte G. Descriptive epidemiology of skin cancer in the Swiss Canton of Vaud. Int J Cancer 1988; 42:811-816.
50. Levi F, Te VC, Randimbison L, Erler G, La Vecchia C. Trends in skin cancer incidence in Vaud: an update, 1976-1998. Eur J Cancer Prev 2001; 10:371-373.
51. Plesko I, Severi G, Obsitnikova A, Boyle P. Trends in the incidence of non-melanoma skin cancer in Slovakia, 1978-1995. Neoplasma 2000; 47:137-142.
52. Watts T, Siziya S, Chokunonga E. Cancer of the skin in Zimbabwe: an analysis based on the Cancer Registry 1986 to 1992. Cent Afr J Med 1997; 43:181-184.
53. Berg D, Otley CC. Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. 1. J Am Acad Dermatol 2002; 47:1-17.
54. Bouwes Bavinck JN, Feltkamp M, Struijk L, ter Schegget J. Human papillomavirus infection and skin cancer risk in organ transplant recipients. J Investig Dermatol Symp Proc 2001; 6:207-211.
55. Lindelof B, Sigurgeirsson B, Gabel H, Stern RS. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000; 143:513-519.
56. Ong CS, Keogh AM, Kossard S, Macdonald PS, Spratt PM. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999; 40:27-34.
57. Naldi L, Fortina AB, Lovati S, et al. Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study. Transplantation 2000; 70:1479-1484.
58. Fuente MJ, Sabat M, Roca J, Lauzurica R, Fernandez-Figueras MT, Ferrandiz C. A prospective study of the incidence of skin cancer and its risk factors in a Spanish Mediterranean population of kidney transplant recipients. Br J Dermatol 2003; 149:1221-1226.
59. Levi F, Randimbison L, Maspoli M, Te VC, La Vecchia C. High incidence of second basal cell skin cancers. Eur J Cancer 2006; 42:656-659.
60. Levi F, La Vecchia C, Te VC, Randimbison L, Erler G. Incidence of invasive cancers following basal cell skin cancer. Am J Epidemiol 1997; 146:734-739.
61. Levi F, Randimbison L, La Vecchia C, Erler G, Te VC. Incidence of invasive cancers following squamous cell skin cancer. Int J Cancer 1997; 72:776-779.
62. Stang A, Jockel KH. Changing patterns of skin melanoma mortality in West Germany from 1968 through 1999. Eur J Cancer 2005; 41:45-60.
63. Hannuksela-Svahn A, Pukkala E, Karvonen J. Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995. Arch Dermatol 1999; 135:781-786.
64. Lewis KG, Weinstock MA. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study. Arch Dermatol 2004; 140:837-842.
65. Lober BA, Lober CW, Accola J. Actinic keratosis is squamous cell carcinoma. J Am Acad Dermatol 2000; 43:881-882.
66. Flaxman AB. Actinic keratoses- Malignant or not? J Am Acad Dermatol 2001; 45:466-467.
67. Johnson M.-LT, Roberts J. Skin conditions and related need for medical care among person 1-74 years. US Department of Health Education and Welfare, Hyattsville, 1978.
68. Frost CA, Green AC, Williams GM. The prevalence and determinants of solar keratoses at a subtropical latitude (Queensland, Australia). Br J Dermatol 1998; 139:1033-1039.
69. Harvey I, Frankel S, Marks R, Shalom D, Nolan-Farrell M. Non-melanoma skin cancer and solar keratoses. I. Methods and descriptive results of the South Wales skin cancer study. Br J Cancer 1996; 74:1302-1307.
70. Memon AA, Tomenson JA, Bothwell J, Friedmann PS. Prevalence of solar damage and actinic keratosis in a Merseyside population. Br J Dermatol 2000; 142:1154-1159.
71. Massa A, Alves R, Amado J, et al. Prevalence of cutaneous lesions in Freixo de Espada a Cinta. Acta Med Port 2000; 13:247-254.
72. Frost C, Williams G, Green A. High incidence and regression rates of solar keratoses in a Queensland community. J Invest Dermatol 2000; 115:273-277.
73. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993; 329:1193-1194.
74. Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1988; 1:795-797.
75. Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol 2003; 49:832-841.
76. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 2005; 41:2040-2059.
77. Zanetti R, Rosso S, Martinez C, et al. The multicentre south European study "Helios." I: Skin characteristics and sunburns in basal cell and squamous cell carcinomas of the skin. Br J Cancer 1996; 73(11):1440-1446.
78. Whiteman DC, Green AC. Melanoma and sun exposure: where are we now? Int J Dermatol 1999; 38:481-489.
79. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005; 41:28-44.
80. Rosso S, Zanetti R, Martinez C, et al. The multicentre south European study "Helios." II: Different sun exposure patterns in the etiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer 1996; 73:1447-1454.
81. Gallagher RP, Hill GB, Bajdik CD, et al. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 1995; 131:157-163.
82. Gallagher RP, Hill GB, Bajdik CD, et al. Sunlight exposure, pigmentation factors, and risk of nonmelanocytic skin cancer. II. Squamous cell carcinoma. Arch Dermatol 1995; 131:164-169.
83. Vitasa BC, Taylor HR, Strickland PT, et al. Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen. Cancer 1990; 65:2811-2817.
84. Harvey I, Frankel S, Marks R, Shalom D, Nolan-Farrell M. Non-melanoma skin cancer and solar keratoses. II analytical results of the South Wales skin cancer study. Br J Cancer 1996; 74:1308-1312.
85. Bastiaens MT, Hoefnagel JJ, Bruijn JA, Westendorp RG, Vermeer BJ, Bouwes Bavinck JN. Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors. J Invest Dermatol 1998; 110:880-884.
86. Lovatt TJ, Lear JT, Bastrilles J, et al. Associations between ultraviolet radiation, basal cell carcinoma site and histology, host characteristics, and rate of development of further tumors. J Am Acad Dermatol 2005; 52:468-473.
87. Siskind V, Whiteman DC, Aitken JF, Martin NG, Green AC. An analysis of risk factors for cutaneous melanoma by anatomical site (Australia). Cancer Cause Control 2005; 16:193-199.
88. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 2005; 41:28-44.
89. English DR, Armstrong BK. Melanocytic nevi in children. I. Anatomic sites and demographic and host factors. Am J Epidemiol 1994; 139:390-401.
90. Kelly JW, Rivers JK, MacLennan R, Harrison S, Lewis AE, Tate BJ. Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren. J Am Acad Dermatol 1994; 30:40-48.
91. Dennis LK, White E, Lee JA, Kristal A, McKnight B, Odland P. Constitutional factors and sun exposure in relation to nevi: a population-based cross-sectional study. Am J Epidemiol 1996; 143:248-256.
92. Dulon M, Weichenthal M, Blettner M, et al. Sun exposure and number of nevi in 5- to 6-year-old European children. J Clin Epidemiol 2002; 55:1075-1081.
93. Carli P, Naldi L, Lovati S, La Vecchia C; Oncology Cooperative Group of the Italian Group for Epidemiologic Research in Dermatology (GISED). The density of melanocytic nevi correlates with constitutional variables and history of sunburns: a prevalence study among Italian schoolchildren. Int J Cancer 2002; 101:375-379.
94. MacLennan R, Kelly JW, Rivers JK, Harrison SL. The Eastern Australian Childhood Nevus Study: site differences in density and size of melanocytic nevi in relation to latitude and phenotype. J Am Acad Dermatol 2003; 48:367-375.
95. Wiecker TS, Luther H, Buettner P, Bauer J, Garbe C. Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood: a risk factor study in 1,812 kindergarten children. Cancer 2003; 97:628-638.
96. Doll R. Cancers weakly related to smoking. Br Med Bull 1996; 52:35-49.
97. Moore S, Johnson N, Pierce A, Wilson D. The epidemiology of lip cancer: a review of global incidence and aetiology. Oral Dis 1999; 5:185-195.
98. Green A, Battistutta D, Hart V, Leslie D, Weedon D. Skin cancer in a subtropical Australian population: incidence and lack of association with occupation. The Nambour Study Group. Am J Epidemiol 1996; 144:1034-1040.
99. De Hertog SA, Wensveen CA, Bastiaens MT, et al. Relation between smoking and skin cancer. J Clin Oncol 2001; 19:231-238.
100. Hakim IA, Harris RB, Ritenbaugh C. Fat intake and risk of squamous cell carcinoma of the skin. Nutr Cancer 2000; 36:155-162.
101. Green A, Williams G, Neale R, et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomized controlled trial. Lancet 1999; 354:723-729.
102. Lichter MD, Karagas MR, Mott LA, Spencer SK, Stukel TA, Greenberg ER. Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. The New Hampshire Skin Cancer Study Group. Arch Dermatol 2000; 136:1007-1011.
103. Ron E, Preston DL, Kishikawa M, et al. Skin tumor risk among atomic-bomb survivors in Japan. Cancer Cause Control 1998; 9:393-401.
104. Saladi R, Austin L, Gao D, et al. The combination of benzo[a]pyrene and ultraviolet A causes an in vivo time-related accumulation of DNA damage in mouse skin. Photochem Photobiol 2003; 77:413-419.
105. Yu RC, Hsu KH, Chen CJ, Froines JR. Arsenic methylation capacity and skin cancer. Cancer Epidemiol Biomarkers Prev 2000; 9:1259-1262.
106. Ramirez CC, Federman DG, Kirsner RS. Skin cancer as an occupational disease: the effect of ultraviolet and other forms of radiation. Int J Dermatol 2005; 44:95-100.
107. Diepgen TL, Drexler H. Skin cancer and occupational disease. Hautarzt 2004; 55:22-27.
108. Stern RS, Laird N. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy follow-up study. Cancer 1994; 73:2759-2764.
109. Stern RS, Nichols KT, Vakeva LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study. N Engl J Med 1997; 336:1041-1045.
110. Stern RS, Lunder EJ. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UVA radiation (PUVA). A meta-analysis. Arch Dermatol 1998; 134:1582-1585.
111. Hannuksela-Svahn A, Sigurgeirsson B, Pukkala E, et al. Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis. Br J Dermatol 1999; 141:497-501.
112. Pieternel CM, Pasker-de-Jong M, Wielink G, et al. Treatment with UVB for psoriasis and nonmelanoma skin cancer. A systematic review of the literature. Arch Dermatol 1999; 135:834-840.
113. Autier P, Dore JF, Lejeune F, et al. Cutaneous malignant melanoma and exposure to sunlamps or sunbeds: an EORTC multicenter case-control study in Belgium, France and Germany. EORTC Melanoma Cooperative Group. Int J Cancer 1994; 58:809-813.
114. Karagas MR, Stannard VA, Mott LA, Slattery MJ, Spencer SK, Weinstock MA. Use of tanning devices and risk of basal cell and squamous cell skin cancers. J Natl Cancer Inst 2002; 94:224-246.
115. Bajdik CD, Gallagher RP, Astrakianakis G, Hill GB, Fincham S, McLean DI. Non-solar ultraviolet radiation and the risk of basal and squamous cell skin cancer. Int J Cancer 1994; 58:809-813.
116. Fry A, Verne J. Preventing skin cancer. BMJ 2003; 326:114-115.
117. Saraiya M, Glanz K, Briss PA, et al. Interventions to prevent skin cancer by reducing exposure to untraviolet radiation: a systematic review. Am J Prev Med 2004; 27:422-466.
118. Stoebner-Dalbarre A, Dafez C, Borrel E, Sancho-Garnier H, Guillot B, Group Epi-CES. Prevention of skin cancer programs: analysis of the impact of randomised trials. Ann Dermatol Venereol 2005; 132:641-647.
119. Livingston PM, White V, Hayman J, Dobbinson S. Sun exposure and sun protection behaviours among Australian adolescents: trends over time. Prev Med 2003; 37:577-584.
120. Prochaska JO. Strong and weak principles for progressing from precontemplation to action on the basis of twelve problem behaviors. Health Psychol 1994; 13:47-51.
121. Halpern AC, Kopp LJ. Awareness, knowledge and attitudes to non-melanoma skin cancer and actinic keratosis among the general public. Int J Dermatol 2005; 44:107-111.
122. Vainio H, Miller AB, Bianchini F. An international evaluation of the cancer-preventive potential of sunscreens. Int J Cancer 2000; 88:838-842.
123. Bastuji-Garin S, Diepgen TL. Cutaneous malignant melanoma, sun exposure, and sunscreen use: epidemiological evidence. Br J Dermatol 2002; 146(suppl. 61):24-30.
124. Dennis LK, Beane Freeman LE, VanBeek MJ. Sunscreen use and the risk for melanoma: a quantitative review. Ann Intern Med 2003; 139:966-978.
125. Johnson K, Davy L, Boyett T, Weathers L, Roetzheim RG. Sun protection practices for children: knowledge, attitudes, and parent behaviors. Arch Pediatr Adolesc Med 2001; 155:891-896.
126. http://www-dep.iarc.fr. (GLOBOCAN 2002 database).